Develops methods that create enzyme‑targeted molecules for therapeutic use across disease areas using advanced chemistry and computational design.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Blacksmith Medicines develops innovative biopharmaceutical approaches that design and advance small molecule inhibitors targeting metal‑dependent enzymes for therapeutic use. The company’s platform focuses on creating medicines with potential applications in areas like oncology, infectious disease, and inflammation by harnessing specialized chemistry and computational techniques to address historically challenging biological targets. It positions itself as a scientific enterprise that broadens drug discovery capabilities through its metalloenzyme‑targeted strategy.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Blacksmith Medicines Management Team
Blacksmith Medicines Valuations & Financials
View real-time NPM data on Blacksmith Medicines stock including daily Blacksmith Medicines stock price estimates, valuation history, and historical share price information. Access Blacksmith Medicines financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Blacksmith Medicines pricing across six independent market signals. Looking for private company due diligence data sources on Blacksmith Medicines? Get in touch to learn more.
Similar Companies
like Blacksmith Medicines
AltruBio
Healthcare & Life Sciences
Develops innovative biologics targeting T-cell checkpoint regulators to treat immunological diseases with safer, longer-lasting therapies.
Acelot, Inc.
Healthcare & Life Sciences
Utilizes predictive computational modeling and structural analytics to streamline small molecule drug discovery for neurodegenerative diseases.
Xenothera
Healthcare & Life Sciences
A biotechnology firm specializing in glyco-humanized antibody therapies to improve outcomes in transplantation and immune-related conditions.
Petfolk
Healthcare & Life Sciences
Provides veterinary care, wellness services, and membership plans for pets through multiple convenient locations.
Iris Telehealth
Healthcare & Life Sciences
Telepsychiatry services for community mental health systems.
Trusted
Healthcare & Life Sciences
Digital employment platform built by nurses for nurses.
Nutcracker Therapeutics
Healthcare & Life Sciences
Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.
FAQ
We have answers
Blacksmith Medicines stock does not trade on public stock exchanges. Blacksmith Medicines stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Blacksmith Medicines stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Blacksmith Medicines Stock does not trade on public stock exchanges. In order to sell Blacksmith Medicines shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Blacksmith Medicines does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Blacksmith Medicines share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Blacksmith Medicines stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Blacksmith Medicines stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Blacksmith Medicines stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Blacksmith Medicines is a private company and has not had an IPO. There is currently no Blacksmith Medicines IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Blacksmith Medicines IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
